Source: Annual Congress 2001 - Diseases associated with organic dust exposure
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. D'Alessandro, I. Folletti, S. Bellocchio, A. Gambelunghe, N. Murgia, A. Monaco, T. Baroni, F. Spinozzi, G. Muzi, G. Abbritti (Perugia, Italy). Induced sputum in the follow-up of hypersensitivity pneumonitis. Eur Respir J 2001; 16: Suppl. 31, 788

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum and BAL from patients with hypersensitivity pneumonitis Source: Eur Respir J 2001; 18: Suppl. 33, 508s Year: 2001 Bronchial hyperresponse in hypersensitivity pneumonitis Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Factors predicting response to azathioprine in chronic hypersensitivity pneumonitis – the importance of BAL lymphocytosis Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018 Hypersensitivity pneumonitis Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Hypersensitivity pneumonitis Source: School Course 2014 - Interstitial lung diseases Year: 2014 Hypersensitivity pneumonitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018 Hypersensitivity pneumonitis Source: ERS Course 2016 Year: 2016 Hypersensitivity pneumonitis Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma Year: 2004 Hypersensitivity pneumonitis Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Proteological assesment of idiopathic pulmonary fibrosis and hypersensitivity pneumonitis by mean of broncho-alveolar lavage Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 The value of lymphocytosis in bronchoalveolar lavage in the differential diagnosis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis Source: Annual Congress 2011 - Work, the environment and respiratory disease Year: 2011 Markers of treatment outcome in hypersensitivity pneumonitis patients Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Differential diagnosis between sarcoidosis and hypersensitivity pneumonitis in bioptic material Source: Eur Respir J 2007; 30: Suppl. 51, 763s Year: 2007 Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis Source: ERJ Open Res, 8 (1) 00474-2021; 10.1183/23120541.00474-2021 Year: 2022 Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Idelalisib-related pneumonitis Source: Eur Respir J 2016; 47: 1280-1283 Year: 2016 Pembrolizumab-induced pneumonitis Source: ERJ Open Res, 3 (2) 00081-2016; 10.1183/23120541.00081-2016 Year: 2017 Bosutinib-related pneumonitis Source: Eur Respir J, 50 (3) 1700930; 10.1183/13993003.00930-2017 Year: 2017 Severe asthma fenotypes by sputum induction Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010